全球心肺運動測試市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計到 2034 年，心肺運動測試市場規模將從 2025 年的 47.6 億美元成長至 93 億美元，2026 年至 2034 年的複合年成長率為 7.72%。

隨著醫療機構日益重視心臟和肺部疾病的早期診斷和功能評估，全球心肺運動試驗市場正穩步擴張。心肺運動試驗系統在醫院、運動醫學中心和研究機構的應用日益廣泛，用於評估運動能力和疾病進展。慢性呼吸系統和心臟疾病盛行率的上升是推動市場需求的主要因素。

成長要素包括代謝車、攜帶式檢測設備和整合診斷軟體的技術進步。人們對預防醫學和健身監測意識提升也促進了市場擴張。此外，新興國家人口老化和醫療費用支出不斷成長，也為這些技術的普及應用創造了有利環境。

展望未來，數位健康平台和遠端監測功能的整合有望簡化臨床工作流程。術前風險評估和復健計劃等應用領域的拓展預計將推動市場成長。隨著技術的不斷創新和對精準診斷需求的日益成長，心肺運動測試市場預計將保持持續穩定的成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球心肺運動測試市場：依產品分類

• 市場分析、洞察與預測
• 單光子發射電腦斷層掃描（SPECT）
• 心肺運動試驗（CPET）系統
• 心臟超音波圖
• 脈搏血氧飽和度分析儀
• 用於壓力測試的血壓計
• 其他

第5章：全球心肺運動測試市場：依應用領域分類

• 市場分析、洞察與預測
• 氧氣攝入量
• 二氧化碳
• 分鐘通氣量
• 無氧工作閾值

第6章：全球心肺運動測試市場：依最終用戶分類

• 市場分析、洞察與預測
• 診斷中心
• 門診中心
• 診所
• 醫院
• 其他

第7章 全球心肺運動測試市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Masimo
  • Hill-Rom Holdings Inc
  • Schiller Healthcare India Pvt. Ltd
  • Vyaire Medical Inc
  • MGC Diagnostics Corporation
  • Cardinal Health
  • Nihon Kohden Corporation
  • COSMED Srl
  • Koninklijke Philips NV
  • GE Healthcare
  • Halma Plc

The Cardiopulmonary Exercise Testing Market size is expected to reach USD 9.30 Billion in 2034 from USD 4.76 Billion (2025) growing at a CAGR of 7.72% during 2026-2034.

The Global Cardiopulmonary Exercise Testing Market is expanding steadily as healthcare providers emphasize early diagnosis and performance assessment of cardiovascular and pulmonary conditions. CPET systems are increasingly used in hospitals, sports medicine centers, and research institutions to evaluate exercise capacity and disease progression. Rising prevalence of chronic respiratory and cardiac disorders is driving market demand.

Growth drivers include technological advancements in metabolic carts, portable testing devices, and integrated diagnostic software. Increasing awareness about preventive healthcare and fitness monitoring is also supporting market expansion. Furthermore, the growing aging population and rising healthcare expenditure in emerging economies are creating favorable conditions for adoption.

Looking ahead, integration of digital health platforms and remote monitoring capabilities will enhance clinical workflow efficiency. Expanding applications in pre-surgical risk assessment and rehabilitation programs are expected to broaden market scope. With continuous innovation and rising demand for precision diagnostics, the cardiopulmonary exercise testing market is positioned for sustainable and consistent growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Single-Photon Emission Computed Tomography (SPECT)
• Cardiopulmonary Exercise Testing (CPET) Systems
• Echocardiogram
• Pulse Oximeters
• Stress Blood Pressure Monitors
• Others

By Application

• Oxygen Uptake
• Carbon Dioxide
• Minute Ventilation
• Anaerobic Threshold

By End User

• Diagnostic Centers
• Ambulatory Centers
• Clinics
• Hospitals
• Others

COMPANIES PROFILED

• Masimo, HillRom Holdings Inc, Schiller Healthcare India Pvt Ltd, Vyaire Medical Inc, MGC Diagnostics Corporation, Cardinal Health, Nihon Kohden Corporation, COSMED srl, Koninklijke Philips NV, GE Healthcare, Halma plc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Single-Photon Emission Computed Tomography (SPECT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Cardiopulmonary Exercise Testing (CPET) Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Echocardiogram Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Pulse Oximeters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Stress Blood Pressure Monitors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Oxygen Uptake Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Carbon Dioxide Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Minute Ventilation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Anaerobic Threshold Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CARDIOPULMONARY EXERCISE TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Masimo
  • 9.2.2 Hill-Rom Holdings Inc
  • 9.2.3 Schiller Healthcare India Pvt. Ltd
  • 9.2.4 Vyaire Medical Inc
  • 9.2.5 MGC Diagnostics Corporation
  • 9.2.6 Cardinal Health
  • 9.2.7 Nihon Kohden Corporation
  • 9.2.8 COSMED Srl
  • 9.2.9 Koninklijke Philips N.V
  • 9.2.10 GE Healthcare
  • 9.2.11 Halma Plc